Cargando…
Predictive diagnosis of the risk of breast cancer recurrence after surgery by single-particle quantum dot imaging
In breast cancer, the prognosis of human epidermal growth factor receptor 2 (HER2)-positive patients (20–25%) has been dramatically improved by the clinical application of the anti-HER2 antibody drugs trastuzumab and pertuzumab. However, the clinical outcomes of HER2-negative cases with a poor progn...
Autores principales: | Gonda, Kohsuke, Miyashita, Minoru, Higuchi, Hideo, Tada, Hiroshi, Watanabe, Tomonobu M., Watanabe, Mika, Ishida, Takanori, Ohuchi, Noriaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585722/ https://www.ncbi.nlm.nih.gov/pubmed/26392299 http://dx.doi.org/10.1038/srep14322 |
Ejemplares similares
-
Quantitative diagnosis of HER2 protein expressing breast cancer by single‐particle quantum dot imaging
por: Miyashita, Minoru, et al.
Publicado: (2016) -
Quantitative diagnostic imaging of cancer tissues by using phosphor-integrated dots with ultra-high brightness
por: Gonda, Kohsuke, et al.
Publicado: (2017) -
Automated Quantification of Extranuclear ERα Using Phosphor-Integrated Dots for Predicting Endocrine Therapy Resistance in HR(+)/HER2(−) Breast Cancer
por: Guo, Zhaorong, et al.
Publicado: (2019) -
Increased centrosome number in BRCA‐related breast cancer specimens determined by immunofluorescence analysis
por: Watanabe, Gou, et al.
Publicado: (2018) -
Prognostic significance of tumor-infiltrating CD8(+) and FOXP3(+) lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study
por: Miyashita, Minoru, et al.
Publicado: (2015)